Finance

Lists
Why is METROPOLIS up 2.62%?
Dive Deeper
METROPOLIS:NSE
Metropolis Healthcare Ltd
₹552.00
+2.62%
(+14.10) 1D
Oct 5, 2:33:36 PM GMT+5:30  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for METROPOLIS...
Open
₹534.85
High
₹552.95
Low
₹532.00
Mkt. cap
114.51B
Avg. vol.
271.82K
Volume
190.63K
Dividend
0.54%
Quarterly dividend
₹0.75
Ex-dividend date
May 19, 2026
P/E ratio
56.85
52-wk high
₹609.05
52-wk low
₹412.25
EPS
₹9.71
No. of employees
4K
Open
₹534.85
High
₹552.95
Low
₹532.00
Mkt. cap
114.51B
Avg. vol.
271.82K
Volume
190.63K
Dividend
0.54%
Quarterly dividend
₹0.75
Ex-dividend date
May 19, 2026
P/E ratio
56.85
52-wk high
₹609.05
52-wk low
₹412.25
EPS
₹9.71
No. of employees
4K
News stories
From web sources and news partners
Profile
Metropolis Healthcare, also known as Metropolis Labs, is an Indian multinational chain of diagnostic labs, with its central laboratory in Mumbai, Maharashtra. Metropolis Healthcare has a chain of 124 clinical laboratories and 2400 collection centers across 7 countries including India. The healthcare company was founded in 1980. The company went public in April 2019. Wikipedia
About Metropolis Healthcare Ltd
CEOVijender Singh
Employees4.48K
Founded1980
Headquarters-
SectorHealth care provider
Websitemetropolisindia.com
Last report
Aug 5, 2026
Fiscal period
Q1 2027
EPS / Est. (INR)
₹2.73 / ₹2.65
+3.07%beat
Revenue / Est. (INR)
4.50B / 4.46B
+0.93%beat
Fiscal Q1 2027 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in INR
Loading Previous Earnings...
Revenue
Net income
All values in INR
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
4.29B
4.06B
4.25B
4.50B
Cost of goods sold
877.48M
792.37M
1.27B
871.01M
Cost of revenue
877.48M
792.37M
1.27B
871.01M
Research and development expenses
49.67M
80.57M
43.07M
63.30M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
953.93M
942.25M
2.92B
1.07B
Operating expense
2.66B
2.64B
2.28B
2.84B
Total operating expenses
3.53B
3.43B
3.55B
3.71B
Operating income
758.17M
629.68M
701.16M
787.90M
Other non operating income
8.91M
90.16M
-64.72M
51.02M
EBT including unusual items
710.26M
571.57M
697.63M
777.12M
EBT excluding unusual items
710.26M
662.53M
663.07M
777.12M
Income tax expense
181.36M
150.70M
188.03M
208.29M
Effective tax rate
25.53%
26.37%
26.95%
26.80%
Other operating expenses
1.33B
1.30B
-1.07B
1.39B
Net income
526.68M
413.86M
509.03M
566.67M
Net profit margin
12.27%
10.20%
11.99%
12.59%
Earnings per share
2.53
2.31
2.46
2.73
Interest and investment income
-
-
38.12M
-
Interest expense
-56.82M
-57.30M
-79.33M
-61.80M
Net interest expenses
-56.82M
-57.30M
-41.21M
-61.80M
Depreciation and amortization charges
324.08M
318.78M
385.90M
324.03M
EBITDA
1.07B
680.74M
774.79M
861.53M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps